Bundle Evaluation in Extra Renal Epuration, Incidence of Thrombosis

University Hospital, Clermont-Ferrand100 enrolled

Overview

This is a prospective observational clinical multicentric study in ICU with acute renal failure requiring renal replacement therapy.

Prospective before / after observational clinical multicentric study on ICU acute kidney injury during renal replacement therapy. Evaluation of incidence and exposure to hemofilter clotting. The after phase will consist in medical measures (help for prescription) and paramedical measures (stop the filtration flow during the patient's mobilization).

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Adults Receiving Renal Replacement Therapy

Interventions

renal replacement therapyOTHER

Prospective observational clinical multicentric study in ICU with acute renal failure requiring renal replacement therapy.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult (age \> 18 years) * Renal replacement therapy (continuous veino-veinous hemofiltration or continuous veino-veinous hemodiafiltration) * Consent of patients Exclusion Criteria: * Use citrate anticoagulation * Age below 18 years

Locations (1)

CHU Clermont-Ferrand

Clermont-Ferrand, France

Outcomes

Primary Outcomes

Hemofilter lifetime

Time frame: at day 1

Secondary Outcomes

Hemofilter clotting risk factors

Time frame: at day 1

hemofiltration duration

Time frame: at day 1

down time value

Time frame: at day 1

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.